Dafna D Gladman

Dafna D Gladman, MD, FRCPC

Prognosis, genetic and theraupeutic studies in the rheumatic diseases particularly:
  • Psoriatic arthritis
  • Systemic lupus erythematosus
  • Rheumatoid arthritis

Related Links

Ann Rheum Dis. 2016 Sep 9;
Orbai AM, de Wit M, Mease P, Shea JA, Gossec L, Leung YY, Tillett W, Elmamoun M, Callis Duffin K, Campbell W, Christensen R, Coates L, Dures E, Eder L, FitzGerald O, Gladman D, Goel N, Grieb SD, Hewlett S, Hoejgaard P, Kalyoncu U, Lindsay C, McHugh N,...
J Rheumatol. 2016 Sep;43(9):1767
Tselios K, Gladman DD, Su J, Urowitz MB
J Rheumatol. 2016 Sep 1;
Eder L, Abji F, Rosen CF, Chandran V, Cook RJ, Gladman DD
Lupus. 2016 Aug 13;
Cramarossa G, Urowitz MB, Su J, Gladman D, Touma Z
J Clin Rheumatol. 2016 Aug;22(5):287-8
Tselios K, Gladman DD, Harvey P, Mak S, Chantal M, Butany J, Urowitz MB
J Rheumatol. 2016 Jul 15;
Sheane BJ, Thavaneswaran A, Gladman DD, Chandran V
Arthritis Rheumatol. 2016 Jul 7;
Abji F, Pollock RA, Liang K, Chandran V, Gladman DD
Semin Arthritis Rheum. 2016 May 25;
Chandran S, Aldei A, Johnson SR, Cheung AM, Salonen D, Gladman DD
Arthritis Care Res (Hoboken). 2016 May 23;
Sheane BJ, Gladman DD, Su J, Urowitz MB

Pages


 

Deputy Director, Centre for Prognosis Studies in the Rheumatic Diseases (part of the UHN Arthritis and Autoimmunity Research Centre)
Co-Director, Lupus Clinic, Toronto Western Hospital (TWH)
Director, Psoriatic Arthritis Program, TWH